DAA program to be expanded in community pharmacies

The Dose Administration Aids (DAA) program will be available to 70,000 more patients each year through community pharmacies, with the Federal Government announcing increased...

Management of apathy in patients with Alzheimer’s disease

People diagnosed with Alzheimer’s disease often experience symptoms of apathy, which can be treated by pharmacological and behavioural interventions. The purpose of this evidence...

Remote Australians at increased risk for diabetes complications

Mortality rates are four times higher for Indigenous patients with diabetes than non-Indigenous Australians, a report has found. The Australian Institute of Health and Welfare...

PSA’s critical role in 7CPA in spotlight

Federal Health Minister Greg Hunt has asserted the critical role that PSA will play in drafting the 7th Community Pharmacy Agreement (CPA), shaping the...

Calculating the risk of glaucoma

More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...

The new normal

A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...